128 related articles for article (PubMed ID: 30422911)
1. Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4).
Costagliola D; Potard V; Lang S; Abgrall S; Duvivier C; Fischer H; Joly V; Lacombe JM; Valantin MA; Mary-Krause M; Rozenberg S
J Acquir Immune Defic Syndr; 2019 Feb; 80(2):214-223. PubMed ID: 30422911
[TBL] [Abstract][Full Text] [Related]
2. Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4).
Guiguet M; Mary-Krause M; Ename B; Costagliola D; Grabar S
Pharmacoepidemiol Drug Saf; 2008 May; 17(5):468-74. PubMed ID: 18324608
[TBL] [Abstract][Full Text] [Related]
3. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Costagliola D;
Arch Intern Med; 2010 Jul; 170(14):1228-38. PubMed ID: 20660842
[TBL] [Abstract][Full Text] [Related]
4. Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
Costagliola D; Potard V; Lang S; de Castro N; Cotte L; Duval X; Duvivier C; Grabar S; Mary-Krause M; Partisani M; Ronot-Bregigeon S; Simon A; Tattevin P; Weiss L; Zucman D; Katlama C; Raffi F; Boccara F
J Infect Dis; 2020 Feb; 221(4):516-522. PubMed ID: 31828320
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study.
Komatsu A; Ikeda A; Kikuchi A; Minami C; Tan M; Matsushita S
Drug Saf; 2018 Sep; 41(9):843-848. PubMed ID: 29623648
[TBL] [Abstract][Full Text] [Related]
6. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV.
Sutton SS; Magagnoli J; Hardin JW; Hsu LI; Beaubrun A; Majethia S; Cummings TH
Curr Med Res Opin; 2020 Oct; 36(10):1635-1642. PubMed ID: 32856940
[TBL] [Abstract][Full Text] [Related]
7. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.
Bedimo R; Maalouf NM; Zhang S; Drechsler H; Tebas P
AIDS; 2012 Apr; 26(7):825-31. PubMed ID: 22301411
[TBL] [Abstract][Full Text] [Related]
8. Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.
Nkhoma ET; Rosenblatt L; Myers J; Villasis-Keever A; Coumbis J
PLoS One; 2016; 11(12):e0166982. PubMed ID: 27941989
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir and bone health.
Grant PM; Cotter AG
Curr Opin HIV AIDS; 2016 May; 11(3):326-32. PubMed ID: 26859637
[TBL] [Abstract][Full Text] [Related]
10. Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.
Morlat P; Vivot A; Vandenhende MA; Dauchy FA; Asselineau J; Déti E; Gerard Y; Lazaro E; Duffau P; Neau D; Bonnet F; Chêne G;
PLoS One; 2013; 8(6):e66223. PubMed ID: 23776637
[TBL] [Abstract][Full Text] [Related]
11. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
[TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
Borges ÁH; Hoy J; Florence E; Sedlacek D; Stellbrink HJ; Uzdaviniene V; Tomazic J; Gargalianos-Kakolyris P; Schmid P; Orkin C; Pedersen C; Leen C; Pradier C; Mulcahy F; Ridolfo AL; Staub T; Maltez F; Weber R; Flamholc L; Kyselyova G; Lundgren JD; Mocroft A;
Clin Infect Dis; 2017 May; 64(10):1413-1421. PubMed ID: 28329090
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study.
Bruyand M; Le Marec F; Lavole A; Leffondre K; Spano JP; Le Moing V; Tattevin P; March L; Cadranel J; Bonnet F; Guiguet M
AIDS; 2015 Jun; 29(9):1105-9. PubMed ID: 26125142
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
Gafni RI; Hazra R; Reynolds JC; Maldarelli F; Tullio AN; DeCarlo E; Worrell CJ; Flaherty JF; Yale K; Kearney BP; Zeichner SL
Pediatrics; 2006 Sep; 118(3):e711-8. PubMed ID: 16923923
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea.
Lee JE; Lee S; Song SH; Kwak IS; Lee SH
Korean J Intern Med; 2019 Mar; 34(2):409-417. PubMed ID: 29020764
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with fractures in HIV-infected persons: which factors matter?
Gedmintas L; Wright EA; Dong Y; Lehmann E; Katz JN; Solomon DH; Losina E
Osteoporos Int; 2017 Jan; 28(1):239-244. PubMed ID: 27421978
[TBL] [Abstract][Full Text] [Related]
17. Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study.
Tsai MS; Chang SY; Lin SW; Kuo CH; Sun HY; Wu BR; Tang SY; Liu WC; Su YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2017 Dec; 50(6):789-797. PubMed ID: 26857335
[TBL] [Abstract][Full Text] [Related]
18. Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.
Grant PM; Kitch D; McComsey GA; Tierney C; Ha B; Brown TT
HIV Clin Trials; 2015; 16(2):66-71. PubMed ID: 25872972
[TBL] [Abstract][Full Text] [Related]
19. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
[TBL] [Abstract][Full Text] [Related]
20. Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
de Monteynard LA; Matheron S; Grabar S; de Truchis P; Gilquin J; Pavie J; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Mahamat A; Dray-Spira R; Simon A; Costagliola D; Abgrall S;
PLoS One; 2018; 13(10):e0205385. PubMed ID: 30379870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
